Company Filing History:
Years Active: 2010-2012
Title: Innovations of Lena Shukla
Introduction
Lena Shukla is a prominent inventor based in London, GB. She has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target specific diseases. With a total of 2 patents, her work is recognized for its potential impact on medical treatments.
Latest Patents
Lena's latest patents include innovative 5-phenylthiazole derivatives that serve as PI3 kinase inhibitors. These compounds, represented by formula I in free or salt form, are designed to treat diseases mediated by phosphatidylinositol 3-kinase. The patents also describe pharmaceutical compositions that incorporate these compounds and outline the processes for their preparation.
Career Highlights
Lena Shukla is currently associated with Novartis AG, a leading global healthcare company. Her role at Novartis allows her to work on cutting-edge research and development projects that aim to improve patient outcomes through innovative therapies.
Collaborations
Throughout her career, Lena has collaborated with notable colleagues, including Ian Bruce and Peter Finan. These partnerships have fostered a collaborative environment that enhances the development of new pharmaceutical solutions.
Conclusion
Lena Shukla's contributions to the field of pharmaceuticals through her patents and collaborations highlight her role as an influential inventor. Her work continues to pave the way for advancements in medical treatments.